Two Sigma Investments, LP Point Biopharma Global Inc. Transaction History

Two Sigma Investments, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.67 - $9.71 $2.47 Million - $3.6 Million	-370,585 Reduced 79.76%	94,042 $627,000
Q2 2023 Aug 14, 2023	BUY	$6.86 - $10.86 $2.09 Million - $3.31 Million	304,665 Added 190.46%	464,627 $4.21 Million
Q1 2023 May 15, 2023	BUY	$6.78 - $8.1 $917,754 - $1.1 Million	135,362 Added 550.25%	159,962 $1.16 Million
Q4 2022 Feb 14, 2023	BUY	$5.72 - $9.78 $140,712 - $240,587	24,600 New	24,600 $179,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.